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Abstract 38 
Purpose: To investigate the effect of manuka honey on Staphylococcus aureus 39 
in order to identify the intracellular target site. 40 
Methods: Mode of inhibition of manuka honey against Staphylococcus aureus 41 
NCTC 10017 was investigated by determining MIC, MBC and the effect of time 42 
on viability. Structural changes were observed by scanning and transmission 43 
electron microscopy of cells suspended for 4 hours at 37ºC in 0.05 mM Tris 44 
buffer containing 10% (w/v) manuka honey and compared to cells in buffer alone 45 
or buffer containing 10 % (w/v) artificial honey (to assess osmotic damage).  46 
Results: A bactericidal mode of inhibition for manuka honey on Staphylococcus 47 
aureus was established.  Marked structural changes in honey-treated cells were 48 
seen only with transmission electron microscopy, where a statistically significant 49 
increase in the number of whole cells with completed septa compared to 50 
untreated cells were observed (p<0.05).   51 
Conclusion: Structural changes found with transmission electron microscopy 52 
suggest that honey-treated cells had failed to progress normally through the cell 53 
cycle and accumulated with fully formed septa at the point of cell division without 54 
separating. Sugars were not implicated in this effect. The staphylococcal target 55 
site of manuka honey involves the cell division machinery.  56 
Keywords: Manuka honey, bacterial cell cycle, cell division, wound infection, 57 
Staphylococcus aureus. 58 
Introduction 59 
Honey is a sweet, sticky substance that is produced by bees following the 60 
collection of either nectar or plant secretions induced by insect damage. It has 61 
been highly valued by generations for thousands of years and its virtues are 62 
documented in ancient religious, secular and medical texts. Therapeutic claims 63 
range from the clearance of wound infection to the enhancement of healing in 64 
chronic wounds. Traditional remedies containing honey were used in the topical 65 
treatment of wounds by diverse ancient civilizations and are still used in remote 66 
communities. New formulations of honey have been introduced into modern 67 
medicine by the development of licensed wound care products and those using 68 
manuka honey are available in Australia, New Zealand, Hong Kong, the 69 
European Union, Canada and USA. Yet some practitioners are reluctant to 70 
accept these products because their mechanism of action is not known. 71 
 72 
Honey is such a complex and variable natural product [1] that the search for 73 
specific inhibitors has been extensive. The antimicrobial activity of honey is 74 
derived from multiple factors, with contributions from high sugar content, low 75 
water content, low acidity, hydrogen peroxide and phytochemicals [2]. Using a 76 
syrup containing the sugars typically found in honey, the inhibitory effects of 77 
diluted natural honey solutions have been demonstrated to be independent of 78 
sugar content [3,4]. Honey exhibits broad spectrum antimicrobial activity that 79 
extends to more than 80 species [2,5]. Inhibition of pathogens capable of 80 
causing wound infection has been demonstrated [3,4,6,7,8], with both 81 
antibiotic-resistant and antibiotic-sensitive strains exhibiting susceptibility to 82 
honey [3,4,9]. An increasing number of clinical reports demonstrate the 83 
clearance of infection by topical application of manuka honey, including the 84 
eradication of methicillin-resistant Staphylococcus aureus (MRSA) from 85 
colonised and infected wounds [10,11,12,13].  86 
Manuka honey is derived from nectar collected by honeybees (Apis mellifera) 87 
foraging on the manuka tree (Leptospermum scoparium) in New Zealand.  88 
Unlike many honeys, the activity of this honey at low dilutions is not limited to 89 
the production of hydrogen peroxide by glucose oxidase, but linked to plant 90 
derived components. One of these is methylglyoxal [14,15] which has been 91 
shown to originate from the high levels of dihyroxyacetone present in the nectar 92 
of manuka flowers [16]. Although the inhibition of Gram positive bacteria by 93 
manuka honey has been reported, cellular target sites and mechanisms of 94 
action have not yet been established, and the effects of honey on the structure 95 
of bacteria have not been studied.  Often it is assumed that the effects of honey 96 
are attributable to osmotic effects. Using Staphylococcus aureus, a common 97 
cause of wound infection, this study was designed to investigate the effects of 98 
manuka honey on bacterial structure that were independent of sugars.  99 
Methods and materials 100 
General 101 
Staphylococcus aureus NCTC 10017 was the test organism used throughout 102 
this study. Additionally two strains of mutant Staph. aureus together with their 103 
respective parental strains were used to determine intracellular target sites. 104 
One parental strain was SH 1000 (reference number 682) and its respective 105 
SigB stress mutant (in SH 1000, TET 5, reference number 1028); the other 106 
parental strain was 8325-4 (reference number 57) with its autolysin atl mutant 107 
(in 8325-4, ERY 5, reference number 187). These cultures were created in 108 
Professor Simon Foster’s laboratory in Sheffield University, UK and kindly 109 
provided to us for this study. 110 
A sample of manuka honey (M109) that was a gift from Prof. Molan at the 111 
University of Waikato in New Zealand was used. Antibacterial potency of the 112 
sample was related to phenol using a standardised bioassay developed in New 113 
Zealand [17] and non-peroxide activity was found to be equivalent to 18 % (w/v) 114 
phenol. The median antibacterial activity for manuka honey (MH) is 15.5 % 115 
(w/v) [17]. 116 
A syrup of the sugars predominantly found in honey (artificial honey or AH) was 117 
used to determine whether cytological changes were caused by osmotic effects 118 
[4]. 100 g AH was prepared as follows: 1.5 g sucrose, 7.5 g maltose, 40.5 g D-119 
fructose and 33.5 g D-glucose were dissolved in 17.5 mL deionised water. 120 
Minimum Inhibitory Concentrations and Minimum Bactericidal Concentrations 121 
MIC was determined in 96-well, flat bottomed microtitre plates (Nunc, Roskilde, 122 
Denmark) using 100 μL double strength nutrient broth (NB; Oxoid, Basingstoke, 123 
UK) and 100 μL MH diluted in deionised water to achieve concentrations 124 
varying by 1 % (w/v) intervals. Wells were inoculated with 1 μL overnight broth 125 
cultures, and total viable counts (TVCs) performed by Miles Misra surface drop 126 
counts, to check retrospectively that each well had received approximately 1 x 127 
106 cells. Briefly to estimate TVCs, samples were serially diluted in ¼ strength 128 
Ringers solution, plated onto nutrient agar (NA; Oxoid, Basingstoke UK) plates 129 
and incubated at 370C for 24 hours. After inoculation, microtitre plates were 130 
incubated at 370C for 24 hours and turbidity was measured at 400 nm in a plate 131 
reader (Anthos Labtec Instruments).  Positive (NB with inoculum) and negative 132 
(NB with manuka honey at the highest respective concentration, without 133 
inoculum) controls were included. The lowest concentration of honey in the 134 
wells without growth was recorded as MIC. MBC was determined by streaking 135 
20 μL from wells without growth onto NA plates, incubating at 370C for 24 hours 136 
and recording the lowest concentration without viable bacteria.  137 
In order to identify possible target sites for MH, MICs of two mutant strains of 138 
Staph. aureus were compared to their parental strains.  139 
Time-kill curve 140 
The inhibitory concentration of MH that was chosen for subsequent 141 
experiments was 10%(w/v) because it was approximately three times the MIC.  142 
The effect of MH on viability of cells was monitored by inoculating 40 μL of an 143 
overnight culture of Staph. aureus NCTC 10017 into 20 mL NB with and without 144 
10 % (w/v) MH and incubated at 370C in a shaking water bath (120 cycles min-145 
1). Samples were removed at known intervals and TVCs determined as above.   146 
Reversibility of inhibitory effects 147 
Cultures of Staph. aureus NCTC 10017 with and without 10 %(w/v) MH in NB 148 
were set up as in time-kill studies and incubated at 370C in a shaking water 149 
bath. At time 0 and at hourly intervals, 100 μL samples were removed from 150 
each of the flasks, transferred to 10 mL NB, incubated overnight at 370C and 151 
viability deduced by the presence of turbidity.  152 
Electron microscopy 153 
Staph. aureus NCTC 10017 was cultivated in 100 mL isosensitest broth (ISB; 154 
Oxoid, Basingstoke, UK) at 370C in a shaking water bath for either 3 hours or 155 
overnight to obtain cells in either the exponential or the stationary phase of 156 
growth, respectively. Cultures were harvested by centrifugation at 3000 g for 30 157 
minutes (MSE Harrier 15/80 centrifuge, Sanyo) at room temperature and 158 
suspended in 0.05 mM Tris buffer (pH 7.2) with and without 10 %(w/v) MH. To 159 
evaluate whether structural changes were attributable to the osmotic effect of 160 
honey, cultures were also suspended in buffer containing 10 %(w/v) artificial 161 
honey solution [4]. Cell suspensions at time 0 and after 4 hours incubation at 162 
370C were fixed and processed for scanning (SEM) and transmission electron 163 
microscopy (TEM) by the methods of Lemar, Turner & Lloyd [18], except that 164 
pellets for (TEM) were embedded in Araldite resin, not Spurr.  165 
Analysis of SEM images 166 
Using the scanning electron microscope (5200LV Jeol, Herts, UK) electron 167 
micrographs of untreated and honey treated cells were prepared. In total 8 168 
samples were processed and at least 6 images of each sample were collected. 169 
To investigate cell surface changes, at least 600 different cells were observed 170 
and counted in typically 8-12 scanning micrographs taken at 10,000 times 171 
magnification for untreated, AH- and MH treated cells. Data was analysed for 172 
statistically significant structural differences by Mann-Whitney test using Mini-173 
Tab (version 15).  174 
Analysis of TEM images 175 
Thin sections of samples were observed by transmission electron microscopy 176 
(1210 Jeol, Herts, UK).  Twelve images of each of 10 samples (5 were 177 
exponential phase cells and 5 were stationary phase) were collected for each 178 
test organism at magnifications between 10,000 and 40,000. Cells were 179 
scrutinised for structural changes, and the presence of completely formed cross 180 
walls (septa) was counted in more than 1000 cells in each of MH-treated and 181 
untreated cultures. Data was analysed by Mann-Whitney test with Mini-Tab 182 
(version 14). 183 
 Results 184 
Minimum Inhibitory Concentrations and Minimum Bactericidal Concentrations 185 
Although inhibition of staphylococci by manuka honey has been reported [4,8], 186 
the culture used in this study had not previously been tested. Also, because 187 
honey is a natural product whose characteristics may vary, it was important to 188 
determine MIC And MBC values at the start of this study to establish 189 
appropriate concentrations to use in time-kill studies and electron microscopy. 190 
Furthermore, altered sensitivity to manuka honey in mutants was used to 191 
provide insight into possible intracellular target sites. 192 
The close proximity of MIC and MBCs values (Table 1) indicated a bactericidal 193 
mode of action for manuka honey with Staph. aureus NCTC 10017 and 194 
increased sensitivity of autolysin (atl) mutant compared to its parental strain 195 
(p<0.001) suggested that the target site was associated with bacterial cell 196 
division.  197 
Time-kill studies 198 
Loss of viability was observed when bacteria were incubated in 10% (w/v) MH 199 
in NB with time compared to untreated cells (Figure 1). Extrapolation of viable 200 
bacterial population sizes in the presence of MH, estimated that the mean time 201 
to achieve a 2 log reduction was 427 minutes.  202 
Reversibility of inhibitory effects 203 
Removing samples from cultures incubated in 10 %(w/v) MH in NB to NB  204 
alone, demonstrated that viable cells were not recovered after 8 hours. This 205 
suggested that the inhibitory effect of MH was irreversible.   206 
Scanning electron microscopy (SEM) 207 
Cultures in both the exponential and the stationary phases of growth were 208 
utilised in structural studies because stationary phase cells are often less 209 
susceptible to antimicrobial agents than exponential cells. However similar 210 
changes were seen in both types of cell and therefore only electron 211 
micrographs of exponential cells are presented here.  212 
 SEM images demonstrated that the appearance of Staph. aureus exposed to 213 
MH and AH was indistinguishable to that of untreated cells and it was deduced 214 
that a bactericidal concentration of MH did not induce marked cellular lysis. 215 
Cells with regular, smooth cell surfaces were observed in SEMs of 99% of the 216 
untreated cells that were incubated in buffer for 4 hours (Figure 2a), as well as 217 
in cells incubated in buffer containing 10 %(w/v) AH (Figure 2b). In the samples 218 
treated with manuka honey for 4 hours few surface changes were found and 219 
90% of the cells retained a smooth surface; there was limited evidence of cell 220 
lysis (Figure 2c).   221 
Transmission electron microscopy (TEM) 222 
As with SEM, in TEM images honey was found to cause minimal alteration to 223 
the cell surface of Staph. aureus and there was limited evidence of cellular 224 
debris and lysis.  Compared to untreated cells (Figure 3a) and cells exposed to 225 
10%(w/v) artificial honey (Figure 3b), cells treated with 10%(w/v) manuka 226 
honey (Figure 3c) showed a difference in that entire cells with fully formed 227 
cross walls were a bit more common.  The percentage of cells with septa in MH 228 
cells increased by 10 % in both exponential and stationary phase cells (Table 229 
2) compared to untreated cells and was statistically significant (p=0.014 and 230 
0.03 respectively). The similar appearance of untreated and AH-treated cells 231 
(p>0.05) indicates that the increased number of cells with septa following 232 
treatment with MH was not likely to be caused by the sugars in honey. 233 
 234 
Discussion 235 
Infection always interrupts the wound healing process and undiluted honey, or 236 
honey mixed with grease and plant extracts, was traditionally applied to the 237 
surface of wounds to treat infections [19]. However, when honey is used 238 
topically in wounds, its osmotic potential causes increased release of fluid 239 
which dilutes honey. It is therefore important to determine the lowest 240 
concentration at which the antimicrobial activity of honey is demonstrated, in 241 
order to judge whether samples of honey will be effective in clinical use. The 242 
sample of manuka honey utilised in this study gave mean MIC and MBC values 243 
of 2.9 and 4.5%(w/v) respectively, which indicated that sufficient activity to 244 
inhibit the test bacteria in laboratory conditions would be present if MH were 245 
diluted approximately 33 and 20 times respectively. Since this extent of dilution 246 
is unlikely to occur in practice, clinicians may be confident that activity will be 247 
retained; of the licensed wound care products that contain manuka honey, 248 
concentration usually exceeds 80% by weight.  It was notable that Staph. 249 
aureus NCTC 10017 was susceptible to relatively low concentrations of 250 
manuka honey, despite being an osmotolerant bacterium.  The ratio of MBC to 251 
MIC was less than 4 and indicates a bactericidal mode of inhibition [20]. 252 
Reductions in viable cells seen in the time-kill experiments (Figure 1) confirmed 253 
a bactericidal mode of action with a time to achieve 2 log reductions estimated 254 
as 427 minutes. Failure to recover viable bacteria after 8 hours in the 255 
reversibility experiment confirmed that the inhibition was irreversible. Clinical 256 
isolates may be less susceptible to antimicrobial agents than reference strains, 257 
yet results with 5 clinical isolates (not shown here) demonstrated a mean 258 
estimated time of 770 minutes to achieve 3 log reductions for MRSA.  259 
The value of electron microscopy in studying cytological effects of antiseptics in 260 
order to elucidate intracellular target sites has been demonstrated for 261 
chlorhexidine [21], iodine [22] and mupirocin [23]. Here the cytological changes 262 
observed with TEM indicate that manuka honey elicited a specific effect in 263 
Staph. aureus that led to a statistically significant increase in numbers of cells 264 
with fully formed septa compared to untreated cells. No structural differences 265 
between the septa of treated and untreated cells were detected; this suggests 266 
that honey-treated cells were able to complete septum formation, but were 267 
unable to separate after the cross walls had formed. It is possible that septa 268 
were formed prematurely in the cell cycle and that cell division was interrupted 269 
because mandatory cellular events had not been completed. Alternatively, cell 270 
division might have been prevented by a defect in the process that facilitates 271 
cell separation. Bacterial cell division is a complex process that has not yet 272 
been fully characterized. Initially structural division proteins such as FtsZ 273 
assemble a ring-like structure at the cell equator and septum formation is 274 
achieved by the deposition of flanking layers of peptidoglycan. Separation of 275 
daughter cells is then mediated by autolysins that cleave the median line of the 276 
septum, with or without cell wall constriction according to species [24].  277 
 278 
In Escherichia coli treated with manuka honey, transcriptome analysis has 279 
recently indicated multiple effects on protein expression [25]. Increased 280 
susceptibility of the autolysin mutant to manuka honey suggests that one of the 281 
effects of manuka honey may be on cell wall components in Staph. aureus. The 282 
intracellular effects of 10%(w/v) manuka honey observed here on Staph. 283 
aureus are unlikely to be due to the sugars present, as the MIC of artificial 284 
honey has been shown to be greater than 30%(v/v) [4]. Furthermore, the cells 285 
exposed to 10%(w/v) artificial honey and observed in SEM and TEM did not 286 
manifest the increased number of cross walls seen in manuka treated cells. 287 
This cell cycle effect of manuka honey in staphylococci has not previously been 288 
reported and we are investigating this mechanism further at present.  289 
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Table 1: Sensitivity of Staphylococcus aureus cultures to manuka honey  364 
 Staph. 
aureus 
NCTN 
10017 
Staph. 
aureus 
parental atl 
Staph. 
aureus 
atl mutant 
Staph. 
aureus 
parental Sig 
B 
Staph. 
aureus 
Sig B 
mutant 
Mean MIC (% w/v), 
range (n) 
2.9, 2.5-
3.4 (9) 
1.45, 1- 1.8 
(10) 
0.5, 0.2- 
0.8 (10) 
1.83, 1.2-
2.2 (10) 
1.6, 1.2- 2 
(10) 
Mean MBC (%w/v), 
range (n) 
4.5, 3.2-5 
(7) 
NT NT NT NT 
p (between parental 
strain and mutant) 
- <0.001 >0.05 
NT: not tested; (n): number of determinations. 365 
Figure 1: The effect of manuka honey on the viability of Staph. aureus NCTC 366 
10017  367 
 368 
Table 2: Percentage of Staph. aureus cells with complete septa in TEM images 369 
 Exponential 
phase cells 
with septa (%) 
Statistical 
significance 
between 
treated and 
untreated 
cells 
Stationary 
phase cells 
with septa (%) 
Statistical 
significance 
between 
treated and 
untreated 
cells 
No honey 16 (n =1025) - 10 (n=1178) - 
10 % (w/v) 
artificial  honey 
 
20 (n=1235) NS NT NT 
10 % (w/v) 
manuka honey 
 
25 (n =1135) p = 0.014 16 (n=1617) p = 0.03 
 370 
n = total number of cells counted; NT = not tested; NS = not significant 371 
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Figure 2: The effect of manuka honey on the appearance of exponential phase 373 
Staphylococcus aureus as seen by scanning electron microscopy 374 
(a) Untreated exponential cells of Staph. aureus incubated in 0.05 mM Tris 375 
buffer pH 7.2 for 4 hours at 370C observed by SEM using 12,000 times 376 
magnification 377 
(b) Exponential cells of Staph. aureus incubated in 0.05 mM Tris buffer pH 7.2 378 
containing 10 % (w/v) artificial honey for 4 hours at 370C observed by SEM 379 
using 10,000 times magnification 380 
(c) Exponential cells of Staph. aureus incubated in 0.05 mM Tris buffer pH 7.2 381 
containing 10 % (w/v) manuka honey for 4 hours at 370C observed by SEM 382 
using 12,000 times magnification 383 
 384 
 385 
 386 
387 
Figure 3: The effect of manuka honey on exponential phase Staphylococcus 388 
aureus as seen by transmission electron microscopy 389 
3a) Exponential cells of Staph. aureus incubated in 0.05 mM Tris buffer pH 7.2 390 
for 4 hours at 370C observed by TEM using 20,000 times magnification 391 
(b) Exponential cells of Staph. aureus incubated in 0.05 mM Tris buffer pH 7.2 392 
containing 10% (w/v) artificial honey for 4 hours at 370C observed by TEM 393 
using 20,000 times magnification 394 
(c) Exponential cells of Staph. aureus incubated in 0.05 mM Tris buffer pH 7.2 395 
containing 10 % (w/v) manuka honey for 4 hours at 370C observed by TEM 396 
using 20,000 times magnification 397 
 398 
 399 
 400 
